Dermatomyositis
📧 Sign up to get email alerts when something new happens for Dermatomyositis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-02-11Clinical Trial Update: A Long-Term Follow-Up Study for Participants Previously Treated With KYV-101
A long-term follow-up study for participants previously treated with KYV-101; recruitment is ongoing across multiple autoimmune diseases.
-
CLINICAL_TRIALS research · 2026-01-29Clinical Trial Update: RCT of Tocilizumab for Anti-MDA5+DM [NA]
A randomized controlled trial evaluating tocilizumab for Anti-MDA5-positive dermatomyositis is currently recruiting at Peking Union Medical …
-
CLINICAL_TRIALS research · 2026-01-28Clinical Trial Update: MIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
The MIHRA PRISMS clinical study for myositis is currently recruiting, sponsored by the Myositis International Health & Research Collaborativ…
-
CLINICAL_TRIALS research · 2026-01-16Clinical Trial Update: Panniculitis in Dermatomyositis
A clinical trial investigating panniculitis in dermatomyositis is currently recruiting at University Hospital, Strasbourg, France.
-
CLINICAL_TRIALS research · 2025-12-23Clinical Trial Update: A Study Evaluating the Effects of GLPG3667 Given as Oral Treatment for up to 24 Weeks in Adults With Dermatomyositis [Phase 2]
Phase 2 clinical trial of GLPG3667 for dermatomyositis is currently active but not recruiting.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-12-22Clinical Trial Update: Efficacy of an Individual Rehabilitation Program in Polymyositis and Dermatomyositis [Phase 2]
Phase 2 study evaluating an individual rehabilitation program for polymyositis and dermatomyositis has completed and reported efficacy resul…
-
CLINICAL_TRIALS trial_result · 2025-12-09Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 in Adults With Dermatomyositis (DM) [Phase 3]
A Phase 3 study evaluating IgPro20 for dermatomyositis in adults was terminated; results have been posted.
-
CLINICAL_TRIALS research · 2025-12-05Clinical Trial Update: Severity Factors of Dermatomyositis in the Caribbean Population - DM-ANTILLES
A clinical trial update on the severity factors of dermatomyositis in the Caribbean population (DM-ANTILLES) currently recruiting.
-
CLINICAL_TRIALS withdrawal · 2025-11-24Clinical Trial Update: Study of Deucravacitinib for Refractory Adults With Dermatomyositis/Juvenile Dermatomyositis [Phase 2]
A Phase 2 study of deucravacitinib for refractory dermatomyositis and juvenile dermatomyositis has been withdrawn. The trial was sponsored b…
-
CLINICAL_TRIALS trial_result · 2025-11-03Clinical Trial Update: A Phase 2 Proof of Concept Study to Evaluate the Efficacy and Safety of Daxdilimab in Participants With Dermatomyositis (DM) or Anti-synthetase Inflammatory Myositis (ASIM) [Phase 2]
Amgen completed a Phase 2 proof-of-concept trial evaluating the efficacy and safety of Daxdilimab in Dermatomyositis and anti-synthetase inf…
-
CLINICAL_TRIALS research · 2025-10-08Clinical Trial Update: Topical Ruxolitinib Cream for Refractory Cutaneous Dermatomyositis [Phase 2]
A Phase 2 clinical trial evaluating topical ruxolitinib cream for refractory cutaneous dermatomyositis is currently recruiting.
-
CLINICAL_TRIALS research · 2025-09-30Clinical Trial Update: CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease [Phase 1, Phase 2]
Miltenyi Biomedicine is conducting Phase 1/2 trials of CAR-T cell therapy targeting B cells for autoimmune diseases, including systemic lupu…
-
CLINICAL_TRIALS research · 2025-09-29Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Dermatomyositis [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy and safety of brepocitinib for dermatomyositis, and the study is currently active but no…
-
CLINICAL_TRIALS research · 2025-09-25Clinical Trial Update: A Study to Evaluate Safety and Efficacy of Empasiprubart in Adults With Dermatomyositis [Phase 2]
Phase 2 clinical trial evaluating safety and efficacy of Empasiprubart in adults with dermatomyositis and myositis; current status is active…
-
CLINICAL_TRIALS trial_result · 2025-09-08Clinical Trial Update: Intralesional Injection of STS in Treatment of Calcinosis [Phase 2]
A Phase 2 clinical trial evaluating intralesional sodium thiosulfate for calcinosis associated with systemic sclerosis and other connective …
-
CLINICAL_TRIALS research · 2025-08-14Clinical Trial Update: Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis [Phase 2]
A Phase 2 clinical trial is planned to evaluate the efficacy and safety of PN-101, an allogeneic mitochondrial therapy, in patients with ref…
-
CLINICAL_TRIALS research · 2025-08-11Clinical Trial Update: Baricitinib in Patients With Relapsing or naïve Dermatomyositis [Phase 3]
A Phase 3 clinical trial is evaluating baricitinib for relapsing or treatment-naïve dermatomyositis and is currently recruiting.
-
CLINICAL_TRIALS other · 2025-07-23Clinical Trial Update: A Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiopathic Inflammatory Myopathy. [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial is evaluating the efficacy and safety of subcutaneous Efgartigimod PH20 (efgartigimod alfa) in adults with …
-
CLINICAL_TRIALS withdrawal · 2025-07-17Clinical Trial Update: Study of M5049 in DM and PM Participants (NEPTUNIA) [Phase 2]
A Phase 2 trial (NEPTUNIA) evaluating M5049 for Dermatomyositis and Polymyositis has been terminated.
-
CLINICAL_TRIALS research · 2025-06-25Clinical Trial Update: Photoacoustic/Ultrasound Imaging in Patients of Dermatomyositis With Calcinosis Cutis: Characteristic Findings and Treatment Response Evaluation [NA]
This clinical trial is evaluating photoacoustic and ultrasound imaging to characterize findings and monitor treatment response in patients w…
-
CLINICAL_TRIALS research · 2025-06-05Clinical Trial Update: Teams Engaged in Accessible Mental Health Interventions for Lupus Erythematosus and Dermatomyositis Stress [NA]
Clinical trial status update about teams developing accessible mental health interventions for lupus erythematosus and dermatomyositis; the …
-
CLINICAL_TRIALS research · 2025-05-21Clinical Trial Update: Study of KYV-101 Anti-CD19 CAR T Therapy in Adult Dermatomyositis [Phase 1]
A Phase 1 trial evaluating KYV-101, an anti-CD19 CAR T therapy, in adults with dermatomyositis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2025-05-20Clinical Trial Update: A 12-Week Open-Label Study to Investigate the Efficacy and Safety of Brepocitinib in Adults With Skin-Predominant Dermatomyositis [Phase 2]
A Phase 2 open-label study evaluating the efficacy and safety of brepocitinib in adults with skin-predominant dermatomyositis has completed.
-
CLINICAL_TRIALS research · 2025-04-11Clinical Trial Update: Anti-CD19 CAR T-Cell Therapy in Refractory Systemic Autoimmune Diseases [Phase 1, Phase 2]
Clinical trial update for anti-CD19 CAR T-cell therapy being explored in refractory systemic autoimmune diseases, including systemic lupus e…
-
CLINICAL_TRIALS research · 2025-04-10Clinical Trial Update: Nebulized MSC-Exos for Anti-MDA5+ RP-ILD: Safety and Efficacy Trial [Phase 1]
A Phase 1 clinical trial evaluating nebulized mesenchymal stem cell-derived exosomes for safety and efficacy in Anti-MDA5-positive dermatomy…